Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05006950 · ClinicalTrials.gov registry record · Phase 1
SPY Fluorescence Imaging Systems and Indocyanine Green to Determine the Percentage of Successful Critical Anatomy Recognition in Laparoscopic Cholecystectomy Surgeries.
A Phase 1 study, sponsored by Stryker Endoscopy.
- Terminated
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT05006950 is a Phase 1 study that was terminated before completion, run by Stryker Endoscopy. The registered enrollment target is 50 participants.
The verdict
NCT05006950, a Phase 1 study, was terminated before completion, sponsored by Stryker Endoscopy.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
This is a prospective single arm, single center study estimating percentage of successful critical anatomy recognition in laparoscopic cholecystectomy surgeries using SPY fluorescence imaging and ICG, with each surgery also providing a white light 360 degree images. The primary objective is to determine the percentage of successful critical anatomy recognition using intra-operative SPY fluorescence imaging and ICG: and to describe complications associated with intra-operative decision making in patients undergoing laparoscopic cholecystectomy.
Interventions
- DEVICE Stryker1688 Fluorescence imaging system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-06-28 |
| Est. Completion | 2022-09-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05006950
The ClinicalTrials.gov registry entry for NCT05006950 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Endoscopy, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stryker1688 Fluorescence imaging system is the first listed.
NCT05006950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05006950 about?
NCT05006950 is a clinical study titled "SPY Fluorescence Imaging Systems and Indocyanine Green to Determine the Percentage of Successful Critical Anatomy Recognition in Laparoscopic Cholecystectomy Surgeries.". This is a prospective single arm, single center study estimating percentage of successful critical anatomy recognition in laparoscopic cholecystectomy surgeries using SPY fluorescence imaging and ICG, with each surgery also providing a white light 360 degree images. The primary objective is to dete...
What is the current status of trial NCT05006950?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2021-06-28. Estimated completion is 2022-09-07.
What interventions are being tested in trial NCT05006950?
The interventions under investigation include: Stryker1688 Fluorescence imaging system (DEVICE).
Who is sponsoring clinical trial NCT05006950?
This trial is sponsored by Stryker Endoscopy, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.